|
|---|
Category:License-Fitness for Duty (FFD) Performance Report
MONTHYEARRS-23-045, Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2022 Per 10 CFR 26.717(c) & 10 CFR 26.2032023-02-28028 February 2023
Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2022 Per 10 CFR 26.717(c) & 10 CFR 26.203
ML23055B2542023-02-24024 February 2023
Annual Fatigue Form for 2022
ML23044A6012023-02-13013 February 2023
Single Positive Test Form Collected on 2/1/2022
ML23044A4202023-02-13013 February 2023
Single Positive Test Form Collected on 2/15/2022
ML23044A4082023-02-13013 February 2023
Annual Report Form for Drug and Alcohol Tests for 2022
ML23044A6002023-02-13013 February 2023
Single Positive Test Form Collected on 2/17/2022
ML23044A5972023-02-13013 February 2023
Single Positive Test Form Collected on 3/8/2022
ML23044A4242023-02-13013 February 2023
Single Positive Test Form Collected on 7/19/2022
ML23044A5982023-02-13013 February 2023
Single Positive Test Form Collected on 12/6/2022
ML23044A4222023-02-13013 February 2023
Single Positive Test Form Collected on 4/5/2022
ML22062B2932022-03-0303 March 2022
Single Positive Test Form Collected on 8/9/2021
ML22062B2922022-03-0303 March 2022
Single Positive Test Form Collected on 02/09/2021
RS-22-029, Constellation, Submittal of Annual Fitness for Duty Performance Data Reports for 20212022-02-25025 February 2022
Constellation, Submittal of Annual Fitness for Duty Performance Data Reports for 2021
ML22055A6422022-02-24024 February 2022
Single Positive Test Form Collected on 02/16/2021
ML22055A6412022-02-24024 February 2022
Single Positive Test Form Collected on 10/05/2021
ML22055A6502022-02-24024 February 2022
Single Positive Test Form Collected on 3/2/2021
ML22055A6372022-02-24024 February 2022
Single Positive Test Form Collected on 02/17/2021
ML22055A6402022-02-24024 February 2022
Single Positive Test Form Collected on 02/16/2021
ML22055A6382022-02-24024 February 2022
Single Positive Test Form Collected on 06/15/2021
ML22055A6392022-02-24024 February 2022
Single Positive Test Form Collected on 02/18/2021
ML22055A6432022-02-24024 February 2022
Single Positive Test Form Collected on 02/03/2021
ML22055A6532022-02-24024 February 2022
Single Positive Test Form Collected on 2/8/2021
ML22055A6602022-02-24024 February 2022
Single Positive Test Form Collected on 08/13/2021
ML22055A6572022-02-24024 February 2022
Single Positive Test Form Collected on 6/17/2021
ML22055A6542022-02-24024 February 2022
Single Positive Test Form Collected on 2/23/2021
ML22055A6512022-02-24024 February 2022
Single Positive Test Form Collected on 7/19/2021
ML22055A6452022-02-24024 February 2022
Single Positive Test Form Collected on 02/08/2021
ML22055A6362022-02-24024 February 2022
Single Positive Test Form Collected on 04/15/2021
ML22055A6582022-02-24024 February 2022
Single Positive Test Form Collected on 2/19/2021
ML22055A6592022-02-24024 February 2022
Single Positive Test Form Collected on 1/20/2021
ML22055A6482022-02-24024 February 2022
Single Positive Test Form Collected on 02/15/2021
ML22055A6552022-02-24024 February 2022
Single Positive Test Form Collected on 8/9/2021
ML22055A6522022-02-24024 February 2022
Single Positive Test Form Collected on 2/8/2021
ML22055A6812022-02-24024 February 2022
Annual Report Form for Drug and Alcohol Tests for 2021
ML22055A6342022-02-24024 February 2022
Single Positive Test Form Collected on 02/17/2021
ML22055A6352022-02-24024 February 2022
Single Positive Test Form Collected on 01/27/2021
ML22055A6562022-02-24024 February 2022
Single Positive Test Form Collected on 8/17/2021
ML22055A6442022-02-24024 February 2022
Single Positive Test Form Collected on 03/08/2021
ML22055A6472022-02-24024 February 2022
Single Positive Test Form Collected on 03/03/2021
ML22055A6492022-02-24024 February 2022
Single Positive Test Form Collected on 02/09/2021
ML22055A6462022-02-24024 February 2022
Single Positive Test Form Collected on 10/14/2021
ML22055A0032022-02-23023 February 2022
Annual Fatigue Reporting Form for 2021
ML21300A0802021-10-27027 October 2021
Single Positive Test Form Collected on 10/19/2020
ML21300A0812021-10-27027 October 2021
Single Positive Test Form Collected on 2/19/2020
ML21300A0792021-10-27027 October 2021
Single Positive Test Form Collected on 07/31/2020
ML21056A0572021-02-25025 February 2021
Annual Fatigue Report Form for 2020
ML21045A0772021-02-14014 February 2021
Annual Report Form for Drug and Alcohol Tests for 2020
ML21045A0782021-02-14014 February 2021
Single Positive Test Form Collected on 11/10/2020
ML21045A0792021-02-14014 February 2021
Single Positive Test Form Collected on 2/13/2020
ML21045A0802021-02-14014 February 2021
Single Positive Test Form Collected on 10/19/2020
2023-02-28
[Table view] |
Text
FFD Program Performance Data Reporting System Annual Reporting Form for Drug and Alcohol Tests Period of Report 2013 Total size of the random testing pool throughout the period (Calculated) 1,148 Average number of
contractors/vendors 270 Average number of
licensee employees 878 10 1,532 0 66 64 0 1 1 1 148 440 0 1 0 Note: 1) All fields required except those marked 'optional'.
- 2) Use Adobe Reader 8 or later for this form to work properly.
- 3) Hold your mouse over a form field to view additional information.
Annual random testing percentage achieved for the testing pool 51.2 Substances Tested Did your program only test for NRC-required substances
AND at the NRC-specified minimum cutoff levels? (Yes / No)
Yes Substance Use Only NRC Cutoff Levels? (Yes / No)
Initial Cutoff Confirmatory Cutoff LOD Testing? (Yes / No)
Comment (Optional)
Alcohol Yes Not Applicable Cocaine Yes Yes Marijuana Yes Yes Amphetamines Yes Yes Opiates Yes Yes PCP Yes Yes FFD Program Random Testing Population and Rate Select Facility LaSalle [50-373; 50-374]
Submission
Update 107 Reason For Testing Licensee Employees Total Number of Positive, Adulterated, Substituted, and Refusal to Test Results Contractors/Vendors Random Pre-Access For Cause Followup Post-Event Does your program conduct LOD testing
permitted in 26.163(a)(2)? (Yes / No)
Yes Yes Identify your HHS-Certified Laboratory(ies)
Medtox 26.717(d) Reporting Positive Initial Drug Test Results (Marijuana and Cocaine) - Licensee Testing Facility (LTF)
Substance Cocaine Marijuana Total (Calculated)
LTF Results MRO Determinations HHS Laboratory Results Enter values into this table if your program terminates an individual's authorization or takes administrative action on the ini tial positive test result.
Identify your Blind Performance Test Sample supplier(s)
ElSohly Laboratory Testing Total Number of Tests Conducted Tests Conducted in the Calendar Year 11 1,748 612 Total (Calculated)- Page 1 of 2 -
No Does your program use a Licensee Testing Facility?
(Yes / No)
Does your program terminate an individual's authorization or take administrative action on initial marijuana or cocaine positive test results
from your licensee testing facility (26.717(d))? (Yes / No)
Annual Report Form (version 1.5.1 - February 12, 2014)(EIE General Submission Portal)
Total Number of "Dilute" Specimens (Special Analyses Testing Conducted) 0 Total Number of "Dilute" Specimen Test Results (Optional)
Special Analyses Testing Results Save to Local PC Print this Report Final Step (Required) -
NRC will consider this form authentic in accordance with 26.11 only when the "Validate & Lock" button has been selected and all errors (i.e., those highlighted in red) have been corrected. The "Validate & Lock" button will change to "Locked" after the data valid ation process has been successfully completed and the form is ready for submission.
Locked Form Locked On:
A pr 29, 2014 at 5:56:03 PM Topic 1 Description (1) Licensee reported 8 tests (2 for Licensee Employees, 6 for C/Vs) under the category "Pre-Access Random." These tests were included under the Pre-Access category.
Summary of Management Actions - 26.717(b)(8)
Topic 1 Other(s)Please elaborate:
Form does not provide a separate field to capture this data.
Topic 2 Description There were six (6) re-analysis performed for this reporting period and all re-confirmed.
Topic 2 Program and System Management Add an additional Topic Summarize actions implemented to improve FFD program performance. As applicable, reference in the topic description audit repo rts, 30-day reports, and/or corrective action reports. If reporting information on more than three topics, select "Others" for Topic 3 to report any addit ional topics.
Person(s) Responsible for Information Provided Company Email Address susan.techau@exeloncorp.com First Name Susan Position Title A A/FFD Program Manager Position Title First Name Last Name Last Name Techau Company Email Address Person 1 (required):
Person 2 (optional):
Annual Report Form (version 1.5.1 - February 12, 2014)- Page 2 of 2 -
Substances Tested -
continued LaSalle [50-373; 50-374]Period of Report:2013
